摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-hydroxybenzaldehyde amidinohydrazone | 4719-73-7

中文名称
——
中文别名
——
英文名称
4-hydroxybenzaldehyde amidinohydrazone
英文别名
(E)-2-(4-hydroxybenzylidene)hydrazine-1-carboximidamide;(4-hydroxy-benzylidenamino)-guanidine;(4-Hydroxy-benzylidenamino)-guanidin;2-[(E)-(4-hydroxyphenyl)methylideneamino]guanidine
4-hydroxybenzaldehyde amidinohydrazone化学式
CAS
4719-73-7
化学式
C8H10N4O
mdl
——
分子量
178.194
InChiKey
XIZFYHNEWSJHQI-VZUCSPMQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    97
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    4-hydroxybenzaldehyde amidinohydrazone2-溴苯乙酮 在 sodium hydroxide 作用下, 以 乙醇 为溶剂, 反应 24.0h, 以1.7%的产率得到(E)-4-(((2-amino-4-phenyl-1H-imidazol-1-yl)imino)methyl)phenol
    参考文献:
    名称:
    作为抗血小板药的1-(亚芳基氨基)-4-芳基-1H-咪唑-2-胺衍生物的合理设计和合成。
    摘要:
    根据先前的研究表明indicating基团和唑环对血小板的抗凝活性具有药理作用,合成了一系列结构中同时具有hydr和唑(咪唑)环的化合物,并评估了它们对血小板凝集的抑制作用。这些1-(亚芳基氨基)-4-芳基-1H-咪唑-2-胺衍生物中的两种,化合物4a [((E)-1-(苄叉基氨基)-4-苯基-1H-咪唑-2-胺]和4 p [(E)-4-苯基-1-((噻吩-2-基亚甲基)氨基)-1H-咪唑-2-胺]的IC50值类似于乙酰水杨酸作为胶原蛋白的血小板聚集诱导剂。
    DOI:
    10.1002/cmdc.201700123
  • 作为产物:
    参考文献:
    名称:
    Thiele; Bihan, Justus Liebigs Annalen der Chemie, 1898, vol. 302, p. 307
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • ALKYLIDENE AMINOGUANIDINE AND SALT THEREOF, MODIFYING COMPOSITION, MODIFIED RUBBER FOR TIRE, RUBBER COMPOSITION FOR TIRE, AND TIRE
    申请人:Mitsubishi Gas Chemical Company, Inc.
    公开号:US20170129850A1
    公开(公告)日:2017-05-11
    Provided is a compound represented by formula (1): wherein X is an acid to form a salt with a guanidine site; and R 1 and R 2 are each independently any selected from the group consisting of a hydrogen atom, a C 1-18 alkyl group, a cycloalkyl group, an aryl group, an alkylaryl group, and an alkenyl group, each of the groups optionally having one or more substituents each containing a sulfur atom, a nitrogen atom, or an oxygen atom.
    提供的化合物由以下式表示: 其中X是一种酸,用于与胍位形成盐;而R1和R2分别独立地选自以下组合:氢原子、C1-18烷基、环烷基、芳基、烷基芳基和烯基,每种基团可选地具有一个或多个含有硫原子、氮原子或氧原子的取代基。
  • Synthesis of aryl-hydrazones via ultrasound irradiation in aqueous medium
    作者:Ana Cristina Lima Leite、Diogo Rodrigo de M. Moreira、Lucas Cunha Duarte Coelho、Frederico Duarte de Menezes、Dalci José Brondani
    DOI:10.1016/j.tetlet.2007.12.103
    日期:2008.2
    The synthesis of aryl-hydrazones from aromatic aldehydes/ketones and hydrazides (semicarbazide, thiosemicarbazide and aminoguanidine) is described using aqueous medium (acid conditions) under ultrasound irradiation with short reaction times (20–30 min), the reactions occurring at room temperature and giving rise to good to excellent yields of the products, along with the diastereoselectivities. The
    描述了使用水性介质(酸性条件)在短时间(20-30分钟)超声辐照下,由芳族醛/酮和酰肼(氨基脲,氨基脲和氨基胍)合成芳基hydr的反应,该反应发生在室温和与非对映选择性一起产生了很好的产品收率。程序也简单干净。
  • [EN] GUANIDINE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF A MEDICAMENT FOR BLOCKING XANTHINE OXIDASE/DEHYDROGENASE<br/>[FR] DERIVES DE GUANIDINE ET LEUR UTILISATION DANS LA PRODUCTION D'UN MEDICAMENT DESTINE A BLOQUER LES XANTHINE OXYDASES/DESHYDROGENASES
    申请人:MELACURE THERAPEUTICS AB
    公开号:WO2001025192A1
    公开(公告)日:2001-04-12
    The present invention relates to guanidine derivatives and pharmaceutically acceptable acid salts thereof. The invention further relates to pharmaceutical preparations containing said compounds, and the use of said compounds for treatment of any type of condition where the expression of xanthine oxidase/xanthine dehydrogenase enzymes is involved. The invention particularly relates to the use of these compounds in the preparation of a medicament for enhancing the survical of a transplanted cell, organ or tissue, or cell, organ or tissue to be transplanted.
    本发明涉及胍衍生物及其药用酸盐。本发明还涉及含有该化合物的制药制剂,以及使用该化合物治疗涉及黄嘌呤氧化酶/黄嘌呤脱氢酶酶表达的任何类型疾病的用途。本发明特别涉及使用这些化合物制备增强移植细胞、器官或组织的存活或待移植的细胞、器官或组织的药物。
  • ALKYLIDENE AMINOGANIDINE AND SALT THEREOF, MODIFIER COMPOSITION, MODIFIED RUBBER FOR TIRE, RUBBER COMPOSITION FOR TIRE, AND TIRE
    申请人:Mitsubishi Gas Chemical Company, Inc.
    公开号:EP3156394A1
    公开(公告)日:2017-04-19
    Provided is a compound represented by formula (1): wherein X is an acid to form a salt with a guanidine site; and R1 and R2 are each independently any selected from the group consisting of a hydrogen atom, a C1-18 alkyl group, a cycloalkyl group, an aryl group, an alkylaryl group, and an alkenyl group, each of the groups optionally having one or more substituents each containing a sulfur atom, a nitrogen atom, or an oxygen atom.
    本发明提供了一种由式(1)表示的化合物: 其中 X 是一种酸,可与胍基点形成盐;R1 和 R2 各自独立地任意选自氢原子、C1-18 烷基、环烷基、芳基、烷芳基和烯基组成的组,每个基团可选择具有一个或多个取代基,每个取代基含有一个硫原子、一个氮原子或一个氧原子。
  • VULCANIZED RUBBER COMPOSITION AND PRODUCTION PROCESS THEREFOR
    申请人:Mitsubishi Gas Chemical Company, Inc.
    公开号:EP3508516A1
    公开(公告)日:2019-07-10
    Provided is a method for producing a vulcanized rubber composition, including: a first kneading step of obtaining a kneaded mixture comprising a rubber component comprising at least one selected from the group consisting of natural rubbers and synthetic rubbers, a filler comprising an inorganic filler, and a sulfur-containing silane coupling agent; a second kneading step of adding sulfur and a vulcanization accelerator to the kneaded mixture, followed by kneading, to thereby obtain an unvulcanized rubber composition; and a vulcanization step of vulcanizing the unvulcanized rubber composition to thereby obtain a vulcanized rubber composition having a glass transition temperature of -30°C to 0°C by; wherein specific aminoguanidines are added, followed by kneading, in the first kneading step.
    提供了一种生产硫化橡胶组合物的方法,包括第一捏合步骤,获得一种捏合混合物,该混合物包含一种橡胶成分,该橡胶成分至少包含一种选自由天然橡胶和合成橡胶组成的组、一种包含无机填料的填料和一种含硫硅烷偶联剂的填料;第二捏合步骤,向捏合混合物中添加硫磺和一种硫化促进剂,然后进行捏合,从而获得一种未硫化橡胶组合物;以及硫化步骤,硫化未硫化橡胶组合物,从而获得玻璃化转变温度为-30°C 至 0°C的硫化橡胶组合物;其中,在第一捏合步骤中加入特定的氨基胍,然后进行捏合。
查看更多